Related references
Note: Only part of the references are listed.Myeloid-derived suppressor cells-new and exciting players in lung cancer
Zhenzhen Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
B cells to the forefront of immunotherapy
Tullia C. Bruno
NATURE (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
Laura Agresta et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
Samuel T. Workenhe et al.
COMMUNICATIONS BIOLOGY (2020)
Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis
Miseon Lee et al.
MODERN PATHOLOGY (2019)
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer
Farhan S. Cyprian et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2019)
Immunological therapy: A novel thriving area for triple-negative breast cancer treatment
Xiangyu Wang et al.
CANCER LETTERS (2019)
STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion
Chuan-xia Zhang et al.
CELL DEATH AND DIFFERENTIATION (2019)
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Janos T. Fekete et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation
Denise E. de Almeida Nagata et al.
CELL REPORTS (2019)
Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2-IL-6 cascade
Yong-Qiang Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3
Xiaoqing Han et al.
CELL DEATH & DISEASE (2019)
SERPIND1 Affects the Malignant Biological Behavior of Epithelial Ovarian Cancer via the PI3K/AKT Pathway: A Mechanistic Study
Qian Guo et al.
FRONTIERS IN ONCOLOGY (2019)
Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Soizic Garaud et al.
JCI INSIGHT (2019)
Platelet endothelial aggregation receptor-1 (PEAR1) is involved in C2C12 myoblast differentiation
Ya Feng Cui et al.
EXPERIMENTAL CELL RESEARCH (2018)
B cells as biomarkers: predicting immune checkpoint therapy adverse events
Shannon M. Liudahl et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
Jacob P. van Vloten et al.
JOURNAL OF IMMUNOLOGY (2018)
Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
Koji Takada et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Transcriptional co-expression regulatory network analysis for Snail and Slug identifies IL1R1, an inflammatory cytokine receptor, to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas
Prit Benny Malgulwar et al.
Oncotarget (2018)
The clinical promise of immunotherapy in triple-negative breast cancer
Praveen Vikas et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Myeloid-derived suppressor cells modulate B-cell responses
Felipe J. N. Lelis et al.
IMMUNOLOGY LETTERS (2017)
Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade
Maria Ouzounova et al.
NATURE COMMUNICATIONS (2017)
Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
In Hye Song et al.
CANCER RESEARCH AND TREATMENT (2017)
PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages An Assessment of 245 Primary and 40 Metastatic Tumors
Erik A. Dill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
Imane Azzaoui et al.
BLOOD (2016)
Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model
Yanhong Wu et al.
BMC IMMUNOLOGY (2016)
The Emerging Role of B Cells in Tumor Immunity
Peiling Tsou et al.
CANCER RESEARCH (2016)
Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response
Monika Majchrzak-Gorecka et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β
Jessica L. Rastad et al.
VIROLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed
Rasha Abu Eid et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario
Sofia Torres et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2015)
The role of oncolytic virus immunotherapies to subvert cancer immune evasion
Samuel T. Workenhe et al.
FUTURE ONCOLOGY (2015)
Natural and therapy-induced immunosurveillance in breast cancer
Guido Kroemer et al.
NATURE MEDICINE (2015)
HISAT: a fast spliced aligner with low memory requirements
Daehwan Kim et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
Maria Gato-Canas et al.
ONCOTARGET (2015)
Oncolytic bovine herpesvirus type 1 as a broad spectrum cancer therapeutic
Breanne P. Cuddington et al.
CURRENT OPINION IN VIROLOGY (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy
Joshua P. Landreneau et al.
CANCER MICROENVIRONMENT (2015)
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
Minoru Miyashita et al.
BREAST CANCER RESEARCH (2015)
Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review
Nickolay Fedchenko et al.
DIAGNOSTIC PATHOLOGY (2014)
Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation
Jung-Mi Lee et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
The Tumor Microenvironment Shapes Lineage, Transcriptional, and Functional Diversity of Infiltrating Myeloid Cells
Kutlu G. Elpek et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
Abdul Qader Sukkurwala et al.
ONCOIMMUNOLOGY (2014)
Trial Watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2014)
Myeloid-derived suppressor cells in breast cancer
Joseph Markowitz et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
Hiroshi Katoh et al.
CANCER CELL (2013)
Enhancement of Antitumor Immunity in Lung Cancer by Targeting Myeloid-Derived Suppressor Cell Pathways
Anandi Sawant et al.
CANCER RESEARCH (2013)
Induction of myelodysplasia by myeloid-derived suppressor cells
Xianghong Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Laura Raccosta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy
Samuel T. Workenhe et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
John Stagg et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
Combining low-dose or metronomic chemotherapy with anticancer vaccines A therapeutic opportunity for lymphomas
Heng Sheng Sow et al.
ONCOIMMUNOLOGY (2013)
Rewiring cancer cell death to enhance oncolytic viro-immunotherapy
Samuel T. Workenhe et al.
ONCOIMMUNOLOGY (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
CD14+S100A9+ Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer
Po-Hao Feng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
Trial watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Mononuclear phagocyte heterogeneity in cancer: Different subsets and activation states reaching out at the tumor site
Damya Laoui et al.
IMMUNOBIOLOGY (2011)
Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy
Paul T. Sobol et al.
MOLECULAR THERAPY (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Herpes Simplex Virus 2 ICP0- Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine
William P. Halford et al.
PLOS ONE (2010)
A scaling normalization method for differential expression analysis of RNA-seq data
Mark D. Robinson et al.
GENOME BIOLOGY (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
Hanh K. Le et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
The role of ICPO-null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma
JL Hummel et al.
MOLECULAR THERAPY (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients:: Correlation with antibody responses
S Gnjatic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
